Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+3.1%
5Y CAGR+279.6%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+3.1%/yr
Annual compound
5Y CAGR
+279.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
788x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 236.61% |
| 2024 | -406.68% |
| 2023 | -92.32% |
| 2022 | 216.11% |
| 2021 | 2.14% |
| 2020 | 0.30% |
| 2019 | -56.81% |
| 2018 | -59.12% |
| 2017 | -170.61% |
| 2016 | 0.00% |